Literature DB >> 5918106

Delayed onset of chloroquine retinopathy.

R P Burns.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5918106     DOI: 10.1056/NEJM196609292751303

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  Current therapy of rheumatoid arthritis.

Authors:  E J Kamin; C V Multz
Journal:  Calif Med       Date:  1969-01

2.  Ophthalmological safety of chloroquine.

Authors:  S P Percival; J Behrman
Journal:  Br J Ophthalmol       Date:  1969-02       Impact factor: 4.638

3.  Delayed onset of chloroquine retinopathy.

Authors:  H Reed; W Karlinsky
Journal:  Can Med Assoc J       Date:  1967-12-02       Impact factor: 8.262

4.  Delayed chloroquine retinopathy.

Authors: 
Journal:  Br Med J       Date:  1967-02-04

Review 5.  Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?

Authors:  Lindsay J Celada; Wonder P Drake
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

6.  Chloroquine retinopathy: is there a safe daily dose?

Authors:  J S Marks
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

Review 7.  Evidence-based therapy for cutaneous sarcoidosis.

Authors:  Christy B Doherty; Ted Rosen
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Improving the risk-benefit relationship and informed consent for patients treated with hydroxychloroquine.

Authors:  Allan J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 9.  Remission-inducing drugs in rheumatoid arthritis.

Authors:  T P Anastassiades
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

10.  Delayed-onset chloroquine retinopathy.

Authors:  M Ehrenfeld; R Nesher; S Merin
Journal:  Br J Ophthalmol       Date:  1986-04       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.